Current Cardiology Reports

, Volume 7, Issue 2, pp 143–147 | Cite as

Advances in nuclear imaging for preoperative risk assessment

  • Jonathan Eddinger
  • Mylan C. Cohen


Myocardial perfusion imaging (MPI) is frequently utilized for preoperative risk assessment. Results are pertinent for longterm risk. MPI, though most frequently applied in intermediate-risk patients, may also be valuable in selected low- and high-risk individuals. Coronary stenting may alter the timing of noncardiac surgery, which should be considered when performing preoperative risk assessment.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Eagle KA, Berger PB, Calkins H, et al.: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). American College of Cardiology 2002. A position statement by ACC/AHA on the role for stress testing in perioperative cardiovascular risk evaluation. Describes current guidelines, which frame the environment for future studies evaluating risk assessment.Google Scholar
  2. 2.
    Mangano DT, Layug EL, Wallace A, Tateo I: The Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996, 335:1713–1720.PubMedCrossRefGoogle Scholar
  3. 3.
    Huber KC, Evans MA, Bresnahan JF, et al.: Outcome of noncardiac operations in patients with severe coronary disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc 1992, 67:15–21.PubMedGoogle Scholar
  4. 4.
    Poornima IG, Miller TD, Chrisitan TF, et al.: Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 2004, 43:194–199. A retrospective analysis of symptomatic patients with low-risk treadmill scores who benefit from further clinical risk stratification and MPI to improve prognostic assessment.PubMedCrossRefGoogle Scholar
  5. 5.
    Beller GA, Watson DD: Risk stratification using stress myocardial perfusion imaging: don't neglect the value of clinical variables. J Am Coll Cardiol 2004, 43:209–212.PubMedCrossRefGoogle Scholar
  6. 6.
    Hubbard BL, Gibbons RJ, Lapeyre AC 3rd, et al.: Identification of severe coronary artery disease using simple clinical parameters. Arch Intern Med 1992, 152:309–312.PubMedCrossRefGoogle Scholar
  7. 7.
    Hachamovitch R, Hayes SW, Friedman JD, et al.: Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004, 43:200–208. Describes for the first time the utility of SPECT imaging in risk stratification of a high probability population for CAD with regard to prognosis and cost efficiency.PubMedCrossRefGoogle Scholar
  8. 8.
    Criqui MH, Langer RD, Fronek A, et al.: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381–386.PubMedCrossRefGoogle Scholar
  9. 9.
    Kelly R, Staines A, MacWalter R, et al.: The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol 2002, 39:219–224.PubMedCrossRefGoogle Scholar
  10. 10.
    Hendel RC, Whitfield SS, Villegas BJ, et al.: Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992, 70:1243–1249.PubMedCrossRefGoogle Scholar
  11. 11.
    Brown KA, Rown M: Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 1993, 21:325–330.PubMedCrossRefGoogle Scholar
  12. 12.
    Cohen MC, Curran PJ, L'Italien GJ, et al.: Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol 1999, 83:1038–1042.PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen MC, Siewers AE, Dickens JD Jr, et al.: Perioperative and long-term prognostic value of dipyridamole Tc-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery. J Nucl Cardiol 2003, 10:464–472. Demonstrates that using MIBI, LAD perfusion abnormalities are associated with poor long-term prognosis and that a normal scan confers low perioperative risk in patients awaiting elective vascular surgery.PubMedCrossRefGoogle Scholar
  14. 14.
    Eagle KA, Coley CM, Newell JB, et al.: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989, 110:859–866.PubMedGoogle Scholar
  15. 15.
    Hashimoto J, Suzuki T, Nakahara T, et al.: Preoperative risk stratification using stress myocardial perfusion scintigraphy with electrocardiographic gating. J Nucl Med 2003, 44:385–390. Demonstrated that ECG gating with SPECT myocardial perfusion confers an incremental prognostic value over conventional nongated stress perfusion imaging in predicting perioperative cardiac events.PubMedGoogle Scholar
  16. 16.
    Germano G, Kiat H, Kavanagh PB, et al.: Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995, 36:2138–2147.PubMedGoogle Scholar
  17. 17.
    Gibbons RJ, Hodge DO, Berman DS, et al.: Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging in coronary artery disease. Circulation 1999, 100:2140–2145.PubMedGoogle Scholar
  18. 18.
    Ladenheim ML, Kotler TS, Pollock BH, et al.: Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 1987, 59:270–277.PubMedCrossRefGoogle Scholar
  19. 19.
    Machecourt J, Longere P, Fagret D, et al.: Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect: study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994, 23:1096–1106.PubMedCrossRefGoogle Scholar
  20. 20.
    Heller GV, Herman SD, Travin MI et al.: Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995, 26:1202–1208.PubMedCrossRefGoogle Scholar
  21. 21.
    Hachamovitch R, Hayes S, Friedman JD, et al.: Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003, 41:1329–1340. Quantifies risk factors associated with increased risk on normal stress myocardial perfusion scans and provides parametric data on the change in risk over time. Includes model for risk assessment after normal scan depending on age, sex, history of CAD, type of stress, and presence of diabetesPubMedCrossRefGoogle Scholar
  22. 22.
    Landesberg G, Mosseri M, Shatz V, et al.: Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J Am Coll Cardiol 2004, 44:569–575. Demonstrated that low-level postoperative troponin elevations occur frequently after major vascular surgery, especially in patients with inducible ischemia on preoperative testing and that coronary revascularization does reduce but not eliminate this risk.PubMedCrossRefGoogle Scholar
  23. 23.
    Landesberg G, Mosseri M, Wolf YG, et al.: Preoperative thallium scanning, selective coronary revascularization and long-term survival following major vascular surgery. Circulation 2003, 108:177–183.PubMedCrossRefGoogle Scholar
  24. 24.
    Kaluza GL, Joseph J, Lee JR, et al.: Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000, 35:1288–1294.PubMedCrossRefGoogle Scholar
  25. 25.
    Wilson SH, Fasseas P, Orford JL, et al.: Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003, 42:234–240.PubMedCrossRefGoogle Scholar
  26. 26.
    Stone GW, Ellis SG, Cox DA, et al.: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350:221–231.PubMedCrossRefGoogle Scholar
  27. 27.
    Park SJ, Shim WH, Ho DS, et al.: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003, 348:1537–1545.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Jonathan Eddinger
    • 1
  • Mylan C. Cohen
  1. 1.Division of Cardiology, Department of MedicineMaine Medical CenterPortlandUSA

Personalised recommendations